Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Axxess signs manufacturing, marketing and distribution deal with Tong By PBR Staff Writer
Axxess Pharma, a US-based provider of nutritional supplements and over-the-counter (OTC) remedies, has signed a long-term manufacturing, marketing and distribution agreement with 8E6Tong Private Company (Tong), a Singapore-registered company.
Production & Manufacturing > OTC > News
Actavis introduces Avycaz in US to treat cIAI and cUTI By PBR Staff Writer
Irish pharmaceutical firm Actavis has launched Avycaz (ceftazidime-avibactam) in the US to treat adult patients with complicated intra-abdominal infections (cIAI) (in combination with metronidazole).
Production & Manufacturing > OTC > News NIH-funded study identifies OTC compounds that may replace damaged cells By PBR Staff Writer
Two over-the-counter (OTC) drugs, an antifungal and a steroid, already on the market may potentially take on new roles as treatments for multiple sclerosis (MS), according to a study partially funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH).
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Actavis gets FDA approval for BOTOX expanded label to treat upper limb spasticity in adults
By PBR Staff Writer
Irish pharmaceutical firm Actavis has secured approval from the US Food and Drug Administration (FDA) for expansion of the BOTOX (onabotulinumtoxinA) label to treat adults with upper limb spasticity, a debilitating neurological condition.
Production & Manufacturing > OTC > News
Hi-Tech to buy Mexican OTC firm Advanced Pharmaceuticals and Nutritionals
By PBR Staff Writer
Hi-Tech Pharmaceuticals has entered into an agreement to acquire Advanced Pharmaceuticals and Nutritionals (APN), a Mexican OTC and dietary supplement company.
Production & Manufacturing > OTC > News
Actavis, Medicines360 launch Liletta 52mg to prevent pregnancy for up to three years
By PBR Staff Writer
Irish pharmaceutical company Actavis and Medicines360, a US-based nonprofit women's health pharmaceutical firm, have launched Liletta (levonorgestrel-releasing intrauterine system) 52mg in the US for use by women to prevent pregnancy for up to three years.
Production & Manufacturing > OTC > News
Mylan offers nearly $29bn to acquire Irish OTC drugmaker Perrigo
By PBR Staff Writer
Generic drugmaker Mylan has offered to acquire Irish over-the-counter (OTC) firm Perrigo in a cash and stock deal valued at nearly $29bn.
Production & Manufacturing > OTC > News
Ablynx begins Phase IIb trial of its anti-IL-6R Nanobody in patients with rheumatoid arthritis
By PBR Staff Writer
Belgium-based biopharmaceutical firm Ablynx has started dosing in the Phase IIb trial of its anti-IL-6R Nanobody, ALX-0061, administered subcutaneously (sc) as a monotherapy in adult patients with active rheumatoid arthritis (RA) who are intolerant to methotrexate (MTX), or for whom MTX is inappropriate.
Production & Manufacturing > OTC > News
Inergetics introduces Bikini Ready and SlimTrim dietary products in Lewis Drug stores
By PBR Staff Writer
Inergetics has made available its Bikini Ready Lifestyle and SlimTrim dietary supplement products at Lewis Drug's locations throughout South Dakota, Iowa and Minnesota in the US.
Production & Manufacturing > OTC > News
Actavis confirms patent challenge for generic of Gilead's Letairis
By PBR Staff Writer
Irish pharmaceutical firm Actavis has submitted an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) seeking approval to market Ambrisentan Tablets, 5mg and 10mg.
Production & Manufacturing > OTC > News
Amneal to buy Actavis' generic pharmaceutical business in Australia
By PBR Staff Writer
Amneal Pharmaceuticals has signed a binding letter of intent to acquire Irish pharmaceutical firm Actavis' generic drug business in Australia for an undisclosed amount.
Production & Manufacturing > OTC > News
Perrigo acquires Belgian OTC firm Omega Pharma for EUR3.8bn
By PBR Staff Writer
Ireland-based Perrigo Company has completed the acquisition of Belgian over-the-counter (OTC) healthcare firm Omega Pharma Invest, for about €3.8bn.
Production & Manufacturing > OTC > News
Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests